Global Drug Testing Market Size to Hit USD 21.30 Billion by 2032, Fueled by Workplace Safety and Rising Substance Abuse – SNS Insider

GlobeNewswire On May 1, 2025 17:10 IST

SNS Insider projects a 5.29% CAGR in the Drug Testing Market from 2024 to 2032, as demand surges across healthcare, transportation, and private sectors.

Austin, May 01, 2025 (GLOBE NEWSWIRE) — Drug Testing Market Size Analysis & Trends:

According to a new report by SNS Insider, the Drug Testing Market size was valued at USD 13.41 billion in 2023 and is expected to reach USD 21.30 billion by 2032, expanding at a CAGR of 5.29% during the forecast period 2024–2032.

Rising awareness of workplace safety, tougher government rules on drug and alcohol usage, and rising drug-related crimes all help to drive the growth. Mandatory testing generates a continual demand for accurate and quick drug screening solutions in fields including transportation, building, healthcare, and law enforcement.

Get a Sample Report of Drug Testing Market@ https://www.snsinsider.com/sample-request/5705

In the United States, drug testing has evolved into a necessary component of corporate compliance initiatives. The U.S. Department of Health and Human Services claims that testing programs are widely adopted, as seen by the over 55 million workplace drug tests performed in 2023 alone. Supported by strong legislation, the prevalence of drug usage, and government spending toward substance abuse prevention programs,

The U.S. drug testing market was valued at USD 5.33 billion in 2023 and is expected to grow to USD 8.20 billion by 2032, registering a CAGR of 4.92% over the forecast period.

Key Drug Testing Companies Profiled in the Report

Abbott Laboratories (Alere iCup Drug Screen, SoToxa Mobile Test System)
Quest Diagnostics (Employer Solutions Drug Testing, Quest Diagnostics Drug Testing Index)
Laboratory Corporation of America Holdings (LabCorp) (Substance Abuse Testing, LabCorp at Home Drug Test Kits)
Thermo Fisher Scientific Inc. (CEDIA Drugs of Abuse Assays, DRI Drug Testing Reagents)
Drägerwerk AG & Co. KGaA (DrugTest 5000 Analyzer, Alcotest 9510)
Siemens Healthineers (Syva EMIT Toxicology Assays, Viva-ProE System)
F. Hoffmann-La Roche Ltd (cobas Integra 400 plus, KIMS Drug Testing Assays)
Bio-Rad Laboratories, Inc. (Tox/See Rapid Drug Screen Cup, Liquichek Urine Toxicology Control)
Alfa Scientific Designs, Inc. (Instant-view Multi-Drug Screen Test, Oral-View Saliva Drug Test)
Lifeloc Technologies, Inc. (FC Series Breathalyzers, EV30 Breath Alcohol Tester)
MPD Inc. (DrugCheck NxStep OnSite Urine Drug Test, DrugCheck SalivaScan Oral Fluid Drug Test)
OraSure Technologies, Inc. (Intercept Oral Fluid Drug Test, Q.E.D. Saliva Alcohol Test)
Psychemedics Corporation (Hair Drug Testing Services, PDT-90 Personal Drug Testing Kit)
American Bio Medica Corporation (Rapid TOX Cup II, OralStat Oral Fluid Drug Test)
AccuBioTech Co., Ltd. (Multi-Drug One Step Test Panel, Saliva Drug Test Cassette)
Premier Biotech, Inc. (OralTox Oral Fluid Drug Test, Premier Bio-Cup)
SureScreen Diagnostics Ltd. (Drugwipe Dual 5 Minute Test, Saliva Drug Testing Kit)
Wondfo Biotech Co., Ltd. (Multi-Drug Urine Test Cup, Saliva Drug Test Strip)
Healgen Scientific LLC (Multi-Drug Rapid Test Cup, SalivaScreen Oral Fluid Drug Test)
Innovacon, Inc. (One Step Drug Screen Test Card, Oral Fluid Drug Test Device)

Drug Testing Market Report Scope

Report Attributes	Details
Market Size in 2023	US$ 13.41 billion
Market Size by 2032	US$ 21.30 billion
CAGR	CAGR of 5.29% From 2024 to 2032
Base Year	2023
Forecast Period	2024-2032
Historical Data	2020-2022
Key Regional Coverage	North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East]), Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America)

Segment analysis

By Product

In 2023, the Consumables segment led the Drug Testing Market, accounting for 33.29% of the total revenue. This Consumables segment, all of which are vital in many screening processes, this section comprises test cups, dip cards, cassettes, and reagents. Because they are cheap, readily available, and frequently needed for replacement in high-volume testing settings such as hospitals, businesses, and drug rehab facilities, consumables are preferred. Demand is driven even more by the growing acceptance of point-of-care drug testing and at-home kits. Standardized consumables are also favoured by regulatory authorities because of their repeatability and adherence to worldwide testing standards, which makes them essential in public and private drug testing programs.

By Sample

With a 75.23% market share, the Urine Samples segment dominated the Drug Testing Market in 2023. Because of its accuracy, non-invasive collection, and cost-effectiveness, urinalysis is generally agreed upon as the gold standard for drug detection. It picks out a broad spectrum of drugs, including benzodiazepines, cannabis, amphetamines, and opioids. Urine drug testing finds great application in schools, probation, and the workplace. For both planned and random tests, they are better because of their capacity to produce fast, consistent findings with a quite long detection range. In government testing organizations and high-throughput labs, urine-based testing for combining with automated systems has further added to its popularity.

By Drug

With a 56.26% share in 2023, the Cannabis/Marijuana segment dominated the market. Because of its popularity, cannabis remains the most tested drug in employment and highway drug tests, even if numerous areas have rising legality for medical and recreational use. Standard testing finds marijuana readily apparent in the human body due to THC’s long retention duration. Quest Diagnostics notes in the United States alone that general staff marijuana positivity rates rose to 4.3% in 2023, which led to tighter company rules and more frequent testing. Testing techniques are changing to guarantee wider coverage when new cannabinoids (Delta-8 THC) enter the market, therefore maintaining cannabis testing as the top priority of market need.

For A Detailed Briefing Session with Our Team of Analysts, Connect with Us Now@ https://www.snsinsider.com/request-analyst/5705

Drug Testing Market Segmentation

By Product

Consumables
Instruments
Rapid Testing Devices
Services

By Sample

Urine Samples
Oral Fluid Samples
Hair Samples
Other Samples

By Drug

Alcohol
Cannabis/Marijuana
Cocaine
Opioids
Amphetamine & Methamphetamine
LSD
Others

By End Use

Drug Testing Laboratories
Workplaces
Hospitals
Others

Regional Analysis

North America dominated the worldwide Drug Testing Market with a 52.25% revenue share in 2023. Driven by strict regulations, high drug use rates, and growing acceptance of job screening, the United States still makes the most contribution to this area. To lower drug use via early identification, government agencies such as SAMHSA (Substance Abuse and Mental Health Services Administration) have started national campaigns. Further improving market penetration in the area are its sophisticated healthcare system, presence of important industry players, and integration of drug testing with criminal justice and sports bodies.

Europe follows closely behind, with significant uptake in drug testing protocols, especially in the UK, Germany, and France. Rising drug-related deaths and laws allowing workplace drug testing have spurred development. Rapid testing technologies, as well as drug-of-abuse monitoring in prisons and colleges, are also becoming increasingly popular in this area.

Rising awareness, urbanization, and increasing cases of drug trafficking and abuse are likely to cause Asia Pacific to see notable expansion throughout the projected timeframe. Preventive testing approaches in both urban and rural sectors are progressively taking the stage in government initiatives in India, China, and Southeast Asia.

Recent Advancements

In late 2023, Abbott Laboratories introduced a revised SoToxaTM mobile drug testing system to improve law enforcement’s roadside screening capacity.
Quest Diagnostics extended its Smart Drug Testing program in January 2024 to incorporate oral fluid testing for recent marijuana usage, therefore enhancing accuracy and detection windows.

Buy a Single-User PDF of Drug Testing Market Analysis & Outlook Report 2024-2032@ https://www.snsinsider.com/checkout/5705

Table of Contents – Major Key Points

1. Introduction

2. Executive Summary

3. Research Methodology

4. Market Dynamics Impact Analysis

5. Statistical Insights and Trends Reporting

5.1 Drug Prevalence and Testing Trends (2023), by Region

5.2 Drug Testing Method Volume and Growth, by Region (2020-2032)

5.3 Healthcare and Workplace Spending on Drug Testing, by Region (Government, Commercial, Private, Out-of-Pocket) (2023)

6. Competitive Landscape

7. Drug Testing Market by Product

8. Drug Testing Market by Sample

9. Drug Testing Market by Drug

10. Drug Testing Market by End Use

11. Regional Analysis

12. Company Profiles

13. Use Cases and Best Practices

14. Conclusion

Related Reports:

Point-of-Care Diagnostics Market Forecast

Drug Screening Market Analysis

Toxicity Testing Outsourcing Market Overview

Drug of Abuse Testing Services Market Report

Occupational Health Market Size & Trends

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

CONTACT: Contact Us: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaShorts takes no editorial responsibility for the same.